Nature Communications · 2022 · 282 citations · 21 references
Veterinary MedicineInfectious DiseasesInternal MedicineClinical EpidemiologyDisease SurveillanceInfectious Disease EpidemiologyRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesSymptom AssessmentDisease Impact AssessmentDisease Onset TimingLong CovidProspective Cohort DataSymptom Onset AnalysisSymptom Onset TimingSymptom Onset Tracking
About 10% of people infected by severe acute respiratory syndrome coronavirus 2 experience post COVID-19 disease. We analysed data from 968 adult patients (5350 person-months) with a confirmed infection enroled in the ComPaRe long COVID cohort, a disease prevalent prospective e-cohort of such patients in France. Day-by-day prevalence of post COVID-19 symptoms was determined from patients' responses to the Long COVID Symptom Tool, a validated self-reported questionnaire assessing 53 symptoms. Among patients symptomatic after 2 months, 85% still reported symptoms one year after their symptom onset. Evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms (e.g., loss of taste/smell); a stable prevalence over time for 18/53 symptoms (e.g., dyspnoea), and an increasing prevalence over time for 8/53 symptoms (e.g., paraesthesia). The disease impact on patients' lives began increasing 6 months after onset. Our results are of importance to understand the natural history of post COVID-19 disease.
21
Persistent Symptoms in Patients After Acute COVID-19
Angelo Carfì, Roberto Bernabei, Francesco Landi · JAMA · 2020 · 4.8K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +9
Chronic illness as biographical disruption
Michael Bury · Sociology of Health & Illness · 1982 · 3.8K citations · Full text